THE CHANGE OF HEPATIC FUNCTIONS AND COMPLICATIONS AFTER TRANSCATHETER EMBOLIZATION THERAPY FOR HEPATIC TUMORS

THE CHANGE OF HEPATIC FUNCTIONS AND COMPLICATIONS AFTER TRANSCATHETER EMBOLIZATION THERAPY FOR HEPATIC TUMORS

Transcatheter embolization therapy (embolization) was performed with gelfoam powder & MMC 10mg in 8 cases (13 times) with hepatic tumors (2 hepatomas & 6 metastatic hepatic tumors). 1) Liver function after embolization is temporarily worsened. The level of GOT, GPT, alkaline phosphatase and...

Full description

Saved in:
Bibliographic Details
Published in:Kita Kantō igaku (The Kitakanto Medical Journal) Vol. 33; no. 4; pp. 337 - 345
Main Authors: IIJIMA, TOSHIHIDE, SAKURAI, KEIICHI, KOJIMA, TAKAHIRO, OSUMI, MASAO, OKADA, TAKASHI, NAKANO, GENICHI, NAKAMURA, TAKUJI
Format: Journal Article
Language:English
Japanese
Published: The Kitakanto Medical Society 1983
Subjects:
Complications
Hepatic tumors
Liver function
Transcatheter embilization therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Transcatheter embolization therapy (embolization) was performed with gelfoam powder & MMC 10mg in 8 cases (13 times) with hepatic tumors (2 hepatomas & 6 metastatic hepatic tumors). 1) Liver function after embolization is temporarily worsened. The level of GOT, GPT, alkaline phosphatase and total bilirubin in serum showed the highest value on 1 or 34 days after embolization but returned to pre-embolization value within 1 week. The albumin was the lowest level at 34 days to 1 week and returned to pre-embolization value gradually within 34 weeks. 2) Post-embolization syndrome was controlled very well with analgesics. 3) The degree of change of liver function and post-embolization syndrome depends on the volume of embolized hepatic areas.
ISSN:0023-1908
1883-6135
DOI:10.2974/kmj1951.33.337